Hong Kong SAR

China Everbright International raised HK$10bn ($1.3bn) from a rights offering last week, with the cash call oversubscribed by shareholders.

Strong demand from bank lenders has allowed Health and Happiness International Holdings to bump up the size of its dual-currency loan to $450m-equivalent.

Fortune Oil PRC Holdings has boosted its borrowing to $430m after attracting 10 participants during syndication.

China Renaissance, the boutique investment bank founded by Fan Bao, is bookbuilding for a Hong Kong IPO to raise around HK$3bn ($377m).

As an old-school, retired banker, I never had to face too much pressure from technology or compliance, both of which seem to be taking over the lives of young bankers.

A week of turmoil in emerging market stocks could not dampen investor enthusiasm for China’s biggest post-summer IPOs, as issuers used a mix of tight cornerstone allocations and compelling equity stories to get across the finish line. John Loh reports.

Shandong Gold Mining launched a HK$6bn ($767m) Hong Kong IPO on Thursday, seeking funds to pay for the acquisition of an Argentinian mine — its first overseas asset.

Bank of China (Hong Kong) has raised $3bn from a Basel III compliant additional tier one transaction, drawing attention for both its size and price.

State Street Corp has appointed Michele Hardeman as head of global markets for Asia Pacific, effective immediately.

Hong Kong-listed CMBC Capital, a subsidiary of China Minsheng Bank, is targeting Taiwanese bank liquidity for an up to HK$1.4bn ($178m) borrowing.

August was generally a healthy month for many global derivatives exchanges, though performance was not quite consistent across the industry.

Hua Medicine, the third biotechnology firm to list in Hong Kong, got across the finish line with an undersubscribed retail book, even though several blue-chip funds threw their weight behind the deal.